Sumitomo Mitsui Trust Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Sell |
|
|||||
|
2025
Q1 | $11.3M | Sell |
|
|||||
|
2024
Q4 | $18.6M | Sell |
|
|||||
|
2024
Q3 | $20.2M | Sell |
|
|||||
|
2024
Q2 | $17.3M | Sell |
|
|||||
|
2024
Q1 | $48.1M | Sell |
|
|||||
|
2023
Q4 | $129M | Sell |
|
|||||
|
2023
Q3 | $112M | Sell |
|
|||||
|
2023
Q2 | $182M | Sell |
|
|||||
|
2023
Q1 | $162M | Sell |
|
|||||
|
2022
Q4 | $116M | Sell |
|
|||||
|
2022
Q3 | $83.5M | Buy |
|
|||||
|
2022
Q2 | $63.4M | Buy |
|
|||||
|
2022
Q1 | $128M | Buy |
|
|||||
|
2021
Q4 | $244M | Buy |
|
|||||
|
2021
Q3 | $239M | Buy |
|
|||||
|
2021
Q2 | $284M | Buy |
|
|||||
|
2021
Q1 | $173M | Buy |
|
|||||
|
2020
Q4 | $116M | Buy |
|
|||||
|
2020
Q3 | $40.6M | Buy |
|